Comprehensive Guide to Brain Health Supplements and FDA Warning Labels

Learn how FDA warning letters, label disclaimers, and dementia evidence guide safer supplement choices.

Brain health supplements are pills, powders, and capsules sold to support memory and thinking. NCCIH finds no conclusive evidence they prevent dementia, and FDA treats Alzheimer's treatment claims as illegal drug claims. FDA places safety responsibility on the maker, not on premarket approval. For caregivers, that shifts the decision from looking for an FDA seal to reading claims closely and asking a clinician before buying.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Table of Contents

What does FDA check before sale?

FDA says it does not approve dietary supplements for safety or effectiveness before marketing. The maker or distributor must sell a safe product that is not adulterated or misbranded, as explained in FDA's dietary-supplement Q&A.

Truthful claims are also the company's duty. You will not find an FDA-approved stamp for memory support on these bottles. Save the label, ingredient list, and dose, and review them with a clinician or pharmacist, especially when prescription drugs are already in use.

When does FDA warn a company?

FDA targets disease claims, not general support language. In February 2019, FDA announced action against 17 companies selling 58 or more products. The action included 12 warning letters and 5 online advisory letters, as described in FDA's February 2019 announcement.

Many were dietary supplements sold as unapproved or misbranded drugs claiming to prevent, treat, or cure Alzheimer's and other serious diseases. FDA's Feb. 5, 2019 warning letter to Pure Nootropics shows how this works. FDA cited Alpha-GPC, Lion's Mane, CDP-choline, piracetam, and ginkgo because website language covered Alzheimer's, dementia, and memory loss.

How do you read the label?

FDA requires a disclaimer on any supplement label that makes a structure/function claim, such as supports memory. The disclaimer must state FDA has not evaluated the claim. It must also state the product is not intended to diagnose, treat, cure, or prevent disease, according to FDA's structure/function claims page.

Use the wording to sort marketing from medicine. Treat these as red flags: If you see a disease claim, set the bottle back and ask a clinician what step fits the care plan. Bring the ad or website wording so the clinician sees the exact promise.

  • claims to prevent, treat, cure, or reverse Alzheimer's, dementia, or memory loss
  • promises of improved memory described as clinically shown without a clear study you can check
  • support language such as supports memory with no disclaimer on the label
  • a website or ad that adds disease claims missing from the bottle

NCCIH advises there is no conclusive evidence dietary supplements prevent cognitive decline, dementia, or Alzheimer's disease. Consumers should treat disease-treatment claims on brain-health labels as warning signs and ask a clinician, as noted in NCCIH's Alzheimer's supplements advice. NCCIH reports ginkgo biloba has not been shown to prevent or slow dementia.

The FTC and the New York Attorney General challenged Prevagen memory claims as false and unsubstantiated. The FTC announced a December 2024 court ruling for the agencies that barred the challenged claims. Bring the product name, dose, and full ingredient list to a clinician visit. Ask whether any ingredient affects prescribed drugs, whether a safer step fits the care plan, and what changes would prompt a second call.


You Might Also Like

HelpDementia.com

Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance

© 2026 HelpDementia.com. All rights reserved.

Educational information only. It is not medical advice and does not replace care from a qualified clinician.